Journal article icon

Journal article

The antibodies 3D12 and 4D12 recognise distinct epitopes and conformations of HLA-E

Abstract:
The commonly used antibodies 3D12 and 4D12 recognise the human leukocyte antigen E (HLA-E) protein. These antibodies bind distinct epitopes on HLA-E and differ in their ability to bind alleles of the major histocompatibility complex E (MHC-E) proteins of rhesus and cynomolgus macaques. We confirmed that neither antibody cross-reacts with classical HLA alleles, and used hybrids of different MHC-E alleles to map the regions that are critical for their binding. 3D12 recognises a region on the alpha 3 domain, with its specificity for HLA-E resulting from the amino acids present at three key positions (219, 223 and 224) that are unique to HLA-E, while 4D12 binds to the start of the alpha 2 domain, adjacent to the C terminus of the presented peptide. 3D12 staining is increased by incubation of cells at 27°C, and by addition of the canonical signal sequence peptide presented by HLA-E peptide (VL9, VMAPRTLVL). This suggests that 3D12 may bind peptide-free forms of HLA-E, which would be expected to accumulate at the cell surface when cells are incubated at lower temperatures, as well as HLA-E with peptide. Therefore, additional studies are required to determine exactly what forms of HLA-E can be recognised by 3D12. In contrast, while staining with 4D12 was also increased when cells were incubated at 27°C, it was decreased when the VL9 peptide was added. We conclude that 4D12 preferentially binds to peptidefree HLA-E, and, although not suitable for measuring the total cell surface levels of MHC-E, may putatively identify peptide-receptive forms.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.3389/fimmu.2024.1329032

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Research group:
Centre for Immuno-Oncology
Role:
Author
ORCID:
0000-0002-0587-7560
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Target Discovery Institute
Research group:
Centre for Immuno-Oncology
Role:
Author
ORCID:
0000-0002-3877-9780
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Research group:
Centre for Immuno-Oncology
Role:
Author


Publisher:
Frontiers Media
Journal:
Frontiers in Immunology More from this journal
Volume:
15
Article number:
1329032
Publication date:
2024-03-20
Acceptance date:
2024-02-27
DOI:
EISSN:
1664-3224


Language:
English
Keywords:
Pubs id:
1647313
Local pid:
pubs:1647313
Deposit date:
2024-02-27
ARK identifier:

Terms of use


Views and Downloads

Views and downloads will return soon






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP